Health Care & Life Sciences » Biotechnology | IBEX Technologies Inc.

IBEX Technologies Inc. | Income Statement

Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,968.80
3,943.10
3,491.10
4,113.70
5,326.70
4,729.60
Cost of Goods Sold (COGS) incl. D&A
1,931.40
2,096.00
1,873.60
2,050.50
2,672.60
2,925.40
Gross Income
2,037.40
1,847.10
1,617.50
2,063.20
2,654.10
1,804.20
SG&A Expense
2,401.60
2,316.60
2,157.30
1,975.20
2,047.40
1,981
EBIT
364.10
469.50
539.80
88.00
606.70
176.80
Unusual Expense
7.40
3.80
581.40
75.70
55.00
65
Non Operating Income/Expense
51.60
44.80
224.00
13.10
89.90
110.90
Interest Expense
26.80
52.30
55.90
63.10
56.20
33.10
Pretax Income
331.90
480.70
209.60
98.10
515.70
34
Income Tax
372.30
-
-
2.50
2,466.20
61.20
Consolidated Net Income
40.40
480.70
209.60
100.60
2,981.80
95.20
Net Income
40.40
480.70
209.60
100.60
2,981.80
95.20
Net Income After Extraordinaries
40.40
480.70
209.60
100.60
2,981.80
95.20
Net Income Available to Common
40.40
480.70
209.60
100.60
2,981.80
95.20
EPS (Basic)
0.00
0.02
0.01
0.00
0.12
-
Basic Shares Outstanding
24,703.20
24,703.20
24,703.20
24,703.20
24,703.20
24,773.20
EPS (Diluted)
0.00
0.02
0.01
0.00
0.12
-
Diluted Shares Outstanding
24,703.20
24,703.20
24,703.20
24,703.20
24,703.20
24,773.20
EBITDA
19.50
62.80
188.30
423.30
880.40
107.60

About IBEX Technologies

View Profile
Address
5485, rue Pare
Montréal Québec H4P 1P7
Canada
Employees -
Website http://www.ibex.ca
Updated 07/08/2019
IBEX Technologies, Inc. manufactures and markets diagnostic products. It manufactures and markets enzymes for biomedical use. The enzymes are used for manufacturers of medical devices, quality control labs and academic research institutions.